Case Reports
doi: 10.1007/s10620-011-1748-1.
Epub 2011 May 20.
Infliximab-induced autoimmune hepatitis with successful switch to adalimumab in a patient with Crohn's disease: the index case
Affiliations
- PMID: 21597977
- DOI: 10.1007/s10620-011-1748-1
Item in Clipboard
Case Reports
Infliximab-induced autoimmune hepatitis with successful switch to adalimumab in a patient with Crohn's disease: the index case
Dig Dis Sci.
2011 Nov.
No abstract available
Similar articles
-
Autoimmune hepatitis induced by infliximab in a patient with Crohn's disease with no relapse after switching to adalimumab.BioDrugs. 2010 Dec 14;24 Suppl 1:25-7. doi: 10.2165/11586210-000000000-00000. BioDrugs. 2010. PMID: 21175232
-
Autoimmune hepatitis during infliximab therapy for Crohn's disease: a case report.J Crohns Colitis. 2011 Jun;5(3):253-5. doi: 10.1016/j.crohns.2010.12.007. Epub 2011 Feb 11. J Crohns Colitis. 2011. PMID: 21575891
-
Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab.Gastroenterol Clin Biol. 2010 Sep;34(8-9):e7-8. doi: 10.1016/j.gcb.2010.01.016. Epub 2010 Feb 26. Gastroenterol Clin Biol. 2010. PMID: 20189334 No abstract available.
-
Adalimumab for orbital myositis in a patient with Crohn's disease who discontinued infliximab: a case report and review of the literature.BMC Gastroenterol. 2013 Apr 4;13:59. doi: 10.1186/1471-230X-13-59. BMC Gastroenterol. 2013. PMID: 23556424 Free PMC article. Review.
-
Adalimumab for the treatment of pediatric Crohn's disease.Expert Rev Clin Immunol. 2015;11(9):963-72. doi: 10.1586/1744666X.2015.1072048. Epub 2015 Jul 27. Expert Rev Clin Immunol. 2015. PMID: 26211396 Review.
Cited by
-
Infliximab-induced autoimmune hepatitis requiring liver transplantation.Clin Case Rep. 2019 Sep 27;7(11):2135-2139. doi: 10.1002/ccr3.2456. eCollection 2019 Nov. Clin Case Rep. 2019. PMID: 31788265 Free PMC article.
-
Rituximab-induced autoimmune hepatitis: A case study and literature review.Can Liver J. 2020 Nov 17;3(4):381-386. doi: 10.3138/canlivj-2020-0009. eCollection 2020 Fall. Can Liver J. 2020. PMID: 35990507 Free PMC article.
-
Biologic and Checkpoint Inhibitor-Induced Liver Injury: A Systematic Literature Review.Hepatol Commun. 2020 Jan 2;4(2):172-184. doi: 10.1002/hep4.1465. eCollection 2020 Feb. Hepatol Commun. 2020. PMID: 32025603 Free PMC article. Review.
-
Infliximab leading to autoimmune hepatitis: an increasingly recognized side effect.Dig Dis Sci. 2014 Oct;59(10):2602-3. doi: 10.1007/s10620-014-3323-z. Dig Dis Sci. 2014. PMID: 25146841 No abstract available.
-
Liver Injury Secondary to Anti-TNF-Alpha Therapy in Inflammatory Bowel Disease: A Case Series and Review of the Literature.Case Rep Gastrointest Med. 2014;2014:956463. doi: 10.1155/2014/956463. Epub 2014 Jan 19. Case Rep Gastrointest Med. 2014. PMID: 24707412 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
